Archive for the ‘society journal retractions’ Category
According to the notice, when the authors continued their research on the same topic, some of the new data raised concerns about what was reported in the 2010 paper. That set off a “number of disputes between authors,” which led them to retract the paper.
This account was supported by the study’s first and corresponding author, Naitik Trivedi, from the A.R. College of Pharmacy & G.H. Patel Institute of Pharmacy in Anand, Gujarat, India. Trivedi told us he believes the previous study didn’t include some relevant parameters, which affected the results.
Trivedi noted that all the authors agree to the retraction, adding: Read the rest of this entry »
Journals have flagged two papers by prominent social psychologist Jens Förster — whose work has been subject to much scrutiny — over concerns regarding the validity of the data.
Förster already has three retractions, following an investigation by his former employer, the University of Amsterdam (UvA) in the Netherlands. In 2014, we reported on the first retraction for Förster for one of three studies with odd patterns that were flagged by the UvA investigation, a 2012 paper in Social Psychological and Personality Science; subsequently, the Netherlands Board on Research Integrity concluded that data had been manipulated. Three statistical experts from the UvA then carried out a more in-depth analysis of 24 publications by Förster, and found eight to have “strong evidence for low scientific veracity.”
Last year, Förster agreed to retract two more papers as part of a deal with the German Society for Psychology (DGPs); those retractions appeared earlier this year. All three papers that Förster has lost until now are from the “strong evidence for low scientific veracity” category. Recently, two more of Förster’s papers from the same category were flagged with notices, but not retracted.
According to an investigation report released by the ORI last year, all 11 studies co-authored by Girija Dasmahapatra, formerly based at Virginia Commonwealth University (VCU) in Richmond, will either be retracted or corrected. In April, Dasmahapatra lost the first of the 11 papers flagged by the ORI in the journal Leukemia. Earlier this month, a second paper from the list was pulled by Clinical Cancer Research.
Dasmahapatra isn’t the only VCU researcher who’s been busy correcting the literature. All 11 papers mentioned in the ORI report list Steven Grant as last author; Paul Dent is a co-author of nine of these studies. Last month, we reported on a retraction in the Journal of Biological Chemistry (JBC) and a mega-correction in Molecular Pharmacology issued for papers by Grant and Dent due to problems with images. Neither paper included Dasmahapatra as a co-author.
We’ve also previously reported on four other errata for image-related issues for papers by Dent (one of which lists Grant as a co-author). Now, we’ve come across another correction in JBC for the pair, which was published last month.
According to the EOC, published in RSC Advances, the paper is now under investigation.
Researchers have retracted and replaced a 2014 paper in JAMA Internal Medicine after realizing a number of errors had affected the findings.
The authors note the mistakes do not have a significant impact on the overall proportion of heart patients who participated in cardiac rehab. However, a number of findings were affected, such as the difference in participation in cardiac rehab defined by race, and how the overall participation has changed throughout the years.
Therefore, JAMA Internal Medicine has published a lengthy notice of retraction and replacement, which explains the errors made in the original paper, and updated the first paper with a new version of the study.
Lead author Samuel Lee, who works at the New Mexico Veterans Affairs (VA) Healthcare System and the University of New Mexico (UNM), requested Eukaryotic Cell retract two papers after identifying multiple instances of fabricated or falsified data. He requested the retraction of a review article based on those papers as well.
In addition, the research is subject to an investigation, Ellie Ghatineh, a production editor at the journal, told us:
The retraction notices, which appear in Clinical Science, mention investigations into the work of Kou-Gi Shyu at the Shin-Kong Wu Ho-Su Memorial Hospital and Taipei Medical University (TMU).
Shyu is listed as being affiliated with both institutions in the original papers, but a TMU official told us Shyu left his teaching role at TMU amidst the probe. Shyr-Yi Lin, professor of medicine and dean of research and development at TMU, noted: Read the rest of this entry »
A California court ruled that fitness empire CrossFit can proceed to trial with its lawsuit against a competitor, alleging it published falsified data that hurt the company’s reputation, according to recently released court documents.
The case pits the popular for-profit CrossFit brand against the non-profit National Strength and Conditioning Association (NSCA), which published the 2013 study in question.
CrossFit claims it lost upwards of $8 million afer researchers concluded that 16 percent of CrossFit participants in a small study left the exercise program because of injury. However, in a 2015 erratum, the authors – led by Steven T. Devor, director of the Exercise Science Laboratory at The Ohio State University — noted that follow up showed only 2 participants out of the 11 drop-outs mentioned their health as a reason.
The study appeared in the Journal of Strength & Conditioning Research, published by CrossFit competitor NSCA, which also promotes fitness programs. CrossFit claims the results in the paper cost it revenues from people paying for seminars at CrossFit, Inc. affiliate gyms.
“CrossFit is now eager to go to trial. More eager than ever,” a CrossFit spokesperson told Retraction Watch: Read the rest of this entry »
A cancer biologist has retracted a 2016 News & Views article in a Nature journal, alleging that the journal tried to censor his writing by asking him to remove passages that criticized another journal (Cell).
Carlo Croce, the sole author of the article in Nature Reviews Clinical Oncology from Ohio State University in Columbus, described the journal’s actions to us as “disgusting” and “worrisome.”
A spokesperson from the journal sent us this statement:
We regret that this situation occurred. We cannot comment beyond the retraction notice.
This isn’t Croce’s first retraction (we just found another recent one, in the Journal of Biological Chemistry, over image problems). He’s also co-authored multiple papers with Alfredo Fusco, a cancer researcher in Italy who has nine retractions under his belt, and is undergoing criminal investigation for scientific misconduct.
Here’s the retraction notice, published in Nature Reviews Clinical Oncology on October 4: Read the rest of this entry »
A second paper about a major randomized trial in Japanese patients with heart disease is being retracted, after an investigation reportedly found multiple problems with the paper.
As predicted by Pharma Japan, Hypertension Research is retracting a 2011 paper, already the subject of two errata. Although a spokesperson said she couldn’t say why the paper was being retracted, as the notice was still in production, editor Toshihiko Ishimitsu told us: Read the rest of this entry »